APA (7th ed.) Citation

Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, & Katsumata T. (2022). Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Dove Medical Press.

Chicago Style (17th ed.) Citation

Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, and Katsumata T. Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Dove Medical Press, 2022.

MLA (9th ed.) Citation

Hata T, et al. Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Dove Medical Press, 2022.